Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis

被引:8
|
作者
Guo, Pengju [1 ]
Wang, Yongxing [1 ]
Han, Yili [1 ]
Wei, Dechao [1 ]
Zhao, Jiahui [1 ]
Li, Mingchuan [1 ]
Jiang, Yongguang [1 ]
Luo, Yong [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Urol, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
renal tumor; pT3a; nephrectomy; cancer-specific survival; systematic review; PERINEPHRIC FAT INVASION; CELL CARCINOMA; PARTIAL NEPHRECTOMY; HIGH-RISK; SINUS FAT; PROGNOSTIC-SIGNIFICANCE; RADICAL NEPHRECTOMY; SIZE; IMPACT; SURVIVAL;
D O I
10.3389/fonc.2021.678459
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To identify the differences in oncological outcomes for patients with different pT3a renal tumor invasion patterns and pathological features. Methods The protocol of this study was registered on PROSPERO (CRD42021234475). Relevant studies were identified by searching the PubMed, Cochrane library, Embase, and Web of Science databases. Cancer-specific survival (CSS) was selected as the endpoint. Pooled hazard ratio (HR) and 95% confidence interval (CI) extracted from multivariate Cox models were evaluated to identify the hazard association. Results A total of 22 studies, which enrolled 12384 patients were included for quantitative synthesis. Sinus fat invasion (SFI) + perinephric fat invasion (PFI) was associated with inferior CSS compared to SFI only (p = 0.02). Comparable CSS was observed between SFI and PFI (p = 0.57). SFI +/- PFI showed inferior CSS compared to PFI only (p = 0.0002). The presence of pelvicalyceal system invasion significantly increased the risk of cancer-specific mortality (p = 0.0005). Renal vein invasion (RVI) indicated poor oncological outcomes in terms of CSS (p = 0.002). The concomitant RVI and fat invasion (FI) significantly increased the risk of deterioration of CSS compared to RVI or FI (p < 0.0001). Multiple invasion patterns translated into a significantly decreased CSS (p < 0.0001). Aggressive tumor behavior, including lymph node involvement (p = 0.006), distant metastases (p < 0.00001), sarcomatoid differentiation (p < 0.0001), necrosis (p < 0.0001), Fuhrman grade III or IV (p < 0.0001), positive margin (p < 0.0001), and tumor size >7cm (p < 0.0001) were the predictors of inferior CSS. The lymphovascular invasion (p = 0.67) was indolent in terms of CSS. Conclusion This study confirmed the heterogenicity of pT3a renal tumors. Multiple invasion patterns could translate into a significantly decreased CSS, and SFI should not be merged in the SFI + PFI group. The presence of PSI or RVI could significantly increase the risk of cancer-specific mortality. Lymph node involvement, distant metastases, sarcomatoid differentiation, necrosis, high Fuhrman grade, positive margin, and size >7cm were the predictors of inferior CSS. A precise-risk grade of CSS for different invasion patterns including comprehensive combinations may be useful for the further refinements of the TNM system. Systematic Review Registration The current study was registered on PROSPERO, and the registration numbers is CRD42021234475.
引用
收藏
页数:13
相关论文
共 41 条
  • [31] Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors?
    Brookman-May, Sabine D.
    May, Matthias
    Wolff, Ingmar
    Zigeuner, Richard
    Hutterer, Georg C.
    Cindolo, Luca
    Schips, Luigi
    De Cobelli, Ottavio
    Rocco, Bernardo
    De Nunzio, Cosimo
    Tubaro, Andrea
    Coman, Ioman
    Truss, Michael
    Dalpiaz, Orietta
    Feciche, Bogdan
    Figenshau, Robert S.
    Madison, Kerry
    Sanchez-Chapado, Manuel
    Santiago Martin, Maria del Carmen
    Salzano, Luigi
    Lotrecchiano, Giuseppe
    Zastrow, Stefan
    Wirth, Manfred
    Sountoulides, Petros
    Shariat, Shahrokh
    Waidelich, Raphaela
    Stief, Christian
    Gunia, Sven
    EUROPEAN UROLOGY, 2015, 67 (05) : 943 - 951
  • [32] Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy
    Ishiyama, Ryo
    Omae, Kenji
    Kondo, Tsunenori
    Iizuka, Junpei
    Yoshida, Kazuhiko
    Fukuda, Hironori
    Tachibana, Hidekazu
    Ishihara, Hiroki
    Kobayashi, Hirohito
    Takagi, Toshio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (02) : 160 - 166
  • [34] The safety outcomes of sodium-glucose cotransporter 2 inhibitors in patients with different renal function: A systematic review and meta-analysis
    Bai, Yaling
    Jin, Jingjing
    Zhou, Wei
    Zhang, Shenglei
    Xu, Jinsheng
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (05) : 1365 - 1374
  • [35] The Impact of Primary Tumor Location on Long-Term Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Systematic Review and Meta-Analysis
    Krajewski, Wojciech
    Nowak, Lukasz
    Malkiewicz, Bartosz
    Chorbinska, Joanna
    Kielb, Pawel
    Poterek, Adrian
    Sporniak, Bartlomiej
    Sut, Michal
    Moschini, Marco
    Lonati, Chiara
    Carando, Roberto
    Teoh, Jeremy Yuen-Chun
    Mori, Keiichiro
    Kaliszewski, Krzysztof
    Szydelko, Tomasz
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [36] Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis and Network Meta-Analysis with Focus on Different Energy Sources
    Sari Motlagh, Reza
    Rajwa, Pawel
    Mori, Keiichiro
    Laukhtina, Ekaterina
    Aydh, Abdulmajeed
    Katayama, Satoshi
    Yanagisawa, Takafumi
    Koenig, Frederik
    Grossmann, Nico C.
    Pradere, Benjamin
    Mostafai, Hadi
    Quhal, Fahad
    Karakiewicz, Pierre I.
    Babjuk, Marek
    Shariat, Shahrokh F.
    JOURNAL OF ENDOUROLOGY, 2022, 36 (04) : 535 - 547
  • [37] Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation
    Swai, Joel
    Zhao Xiexiong
    Noube, Julie-Raisa
    Ming Gui
    BMC NEPHROLOGY, 2020, 21 (01)
  • [38] Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation
    Joel Swai
    Xiexiong Zhao
    Julie-Raisa Noube
    Gui Ming
    BMC Nephrology, 21
  • [39] Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria
    Hamilton, Zachary A.
    Capitanio, Umberto
    Pruthi, Deepak
    Ghali, Fady
    Larcher, Alessandro
    Patel, Devin N.
    Eldefrawy, Ahmed
    Patel, Sunil
    Cotta, Brittney H.
    Bradshaw, Aaron W.
    Meagher, Margaret F.
    Miller, Nathan S.
    Carenzi, Cristina
    Wan, Fang
    Liss, Michael A.
    McGregor, Thomas
    Montorsi, Francesco
    Derweesh, Ithaar H.
    UROLOGY, 2020, 138 : 60 - 68
  • [40] Re: Sabine D. Brookman-May, Matthias May, Ingmar Wolff, et al. Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA Project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? Eur Urol 2015;67:943-51
    Borghesi, Marco
    La Manna, Gaetano
    Schiavina, Riccardo
    EUROPEAN UROLOGY, 2016, 69 (05) : E99 - E100